We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+10.05%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$575M
AUM Growth
+$41.8M
Cap. Flow
+$22.9M
Cap. Flow %
3.98%
Top 10 Hldgs %
38.88%
Holding
304
New
47
Increased
33
Reduced
40
Closed
43

Sector Composition

Rank Sector Weight
1 Energy 16.36%
2 Healthcare 12.76%
3 Consumer Discretionary 11.76%
4 Industrials 11.27%
5 Technology 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AITRU
276
DELISTED
AI Transportation Acquisition Corp Unit
AITRU
-99,900
Closed -$1.02M
BNIX
277
DELISTED
Bannix Acquisition Corp. Common Stock
BNIX
-65,718
Closed -$708K
ALSA
278
DELISTED
Alpha Star Acquisition Corp
ALSA
-49,850
Closed -$558K
EGIO
279
DELISTED
Edgio, Inc. Common Stock
EGIO
-863
Closed -$11.8K
PGTI
280
DELISTED
PGT, Inc.
PGTI
-55,156
Closed -$2.24M
AYX
281
DELISTED
Alteryx Inc
AYX
-54,650
Closed -$2.58M
KRTX
282
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-29,650
Closed -$9.38M
SPLK
283
DELISTED
Splunk Inc
SPLK
-190,600
Closed -$29M
CYT
284
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
-1,026,000
Closed -$3.12M
TGH
285
DELISTED
Textainer Group Holdings limited
TGH
-141,350
Closed -$6.95M
SOVO
286
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
-304,900
Closed -$6.72M
ROVR
287
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
-360,950
Closed -$3.93M
RYZB
288
DELISTED
RayzeBio, Inc. Common Stock
RYZB
-38,850
Closed -$2.42M
GRCL
289
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
-34,300
Closed -$344K
VHAQ.RT
290
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
-83,100
Closed -$4.99K
ICVX
291
DELISTED
Icosavax, Inc. Common Stock
ICVX
-167,000
Closed -$2.63M
NRACW
292
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
-12,566
Closed -$128
IMGN
293
DELISTED
Immunogen Inc
IMGN
-624,750
Closed -$18.5M
QFTA
294
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
-225,000
Closed -$2.41M
ESMT
295
DELISTED
EngageSmart, Inc.
ESMT
-401,000
Closed -$9.18M
ORTX
296
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-192,650
Closed -$3.17M
OTECW
297
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
-93,100
Closed -$2.19K
MRTX
298
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-219,513
Closed -$12.9M
BVH
299
DELISTED
Bluegreen Vacations Holding Corporation
BVH
-10,850
Closed -$815K
CHS
300
DELISTED
Chicos FAS, Inc.
CHS
-720,200
Closed -$5.46M

Similar funds

Gabelli & Co Investment Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Gabelli & Co Investment Advisers held 304 positions worth $575M, up 7.8% from $533M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Gabelli & Co Investment Advisers deployed $22.9M of net new capital in Q1 2024, opening 47 new positions and adding to 33 existing holdings. Its largest new stake was MASONITE INTERNATIONAL CORP: 119,750 shares worth $15.7M.

By sector, the portfolio is most concentrated in Energy at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Lennar Class B, an estimated $3.73M trimmed.

  • Gabelli & Co Investment Advisers's largest Q1 2024 buy was MASONITE INTERNATIONAL CORP: 119,750 shares worth $15.7M.
  • Gabelli & Co Investment Advisers added most to US Steel in Q1 2024, an estimated $8.27M increase.
  • Gabelli & Co Investment Advisers's biggest Q1 2024 reduction was Lennar Class B, cutting an estimated $3.73M.
  • Gabelli & Co Investment Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $29M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 39% of its $575M portfolio in Q1 2024.
  • Gabelli & Co Investment Advisers opened 47 new positions and closed 43 in Q1 2024.
  • Gabelli & Co Investment Advisers's portfolio value rose 7.8% quarter-over-quarter to $575M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2024, filed 14 May 2024.